Resynchronization therapy jumps forward with 3 new studies that support but push the envelope of a new guideline statement on physiologic pacing for heart failure.
Prophylactic use of antiemetic, antipyretic, or antibiotic drugs in older patients with acute stroke did not reduce the risk of a poor functional outcome in the PRECIOUS trial.
It s actually two leadless pacemakers, one atrial and the other ventricular, linked as if in a wireless network, that together maintained true AV synchronous pacing in a short-term study.
The copper chelator trientine was well tolerated and lowered NT-proBNP levels in patients with heart failure and reduced ejection fraction in a phase 2 study.